A multicenter, randomized, double-blind, placebo-controlled study to evaluate the dose response of OPC-41061 in congestive heart failure patients with extracellular volume expansion
Latest Information Update: 13 May 2016
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 17 Dec 2005 New trial record.